S
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Scott A. Stuart's research investigates therapeutic interventions for conditions such as melanoma and diabetes. His work on melanoma cells explores intermittent treatment strategies to delay drug resistance by employing adaptive resensitization. In the context of diabetes, Stuart's research focuses on therapies aimed at repairing skeletal deterioration. He has published on the reversal of diabetic bone signatures in mice using anabolic therapies.
Stuart collaborates with several researchers at the University of Arkansas for Medical Sciences, including Amy Y. Sato, Teresita Bellido, Nisreen Akel, and Gaston Troncoso, with whom he shares multiple publications. His scholarly output includes 14 publications and has garnered 350 citations, with an h-index of 6. He has been active in research recently, with his most recent publication in 2023.
Metrics
- h-index: 6
- Publications: 14
- Citations: 351
Selected Publications
-
THU346 Repairing Skeletal Deterioration In Diabetes With Bone Anabolic Therapies (2023)
-
Author Correction: Reversal of the diabetic bone signature with anabolic therapies in mice (2023)
Collaboration Network
Top Collaborators
Silvia Marino
University of Arkansas for Medical Sciences (US)
2 shared publications
- Author Correction: Reversal of the diabetic bone signature with anabolic therapies in mice
- THU346 Repairing Skeletal Deterioration In Diabetes With Bone Anabolic Therapies
Nisreen Akel
University of Arkansas for Medical Sciences
2 shared publications
In database
- Author Correction: Reversal of the diabetic bone signature with anabolic therapies in mice
- THU346 Repairing Skeletal Deterioration In Diabetes With Bone Anabolic Therapies
Shenyang Li
University of Arkansas for Medical Sciences (US)
2 shared publications
- Author Correction: Reversal of the diabetic bone signature with anabolic therapies in mice
- THU346 Repairing Skeletal Deterioration In Diabetes With Bone Anabolic Therapies
Meloney Cregor
University of Arkansas for Medical Sciences (US)
2 shared publications
- Author Correction: Reversal of the diabetic bone signature with anabolic therapies in mice
- THU346 Repairing Skeletal Deterioration In Diabetes With Bone Anabolic Therapies
Betiana Perez
University of Arkansas for Medical Sciences
2 shared publications
In database
- Author Correction: Reversal of the diabetic bone signature with anabolic therapies in mice
- THU346 Repairing Skeletal Deterioration In Diabetes With Bone Anabolic Therapies
Gaston Troncoso
University of Arkansas for Medical Sciences
2 shared publications
In database
- Author Correction: Reversal of the diabetic bone signature with anabolic therapies in mice
- THU346 Repairing Skeletal Deterioration In Diabetes With Bone Anabolic Therapies
Jomeeka Meeks
University of Arkansas for Medical Sciences
2 shared publications
In database
- Author Correction: Reversal of the diabetic bone signature with anabolic therapies in mice
- THU346 Repairing Skeletal Deterioration In Diabetes With Bone Anabolic Therapies
Amy Y. Sato
University of Arkansas for Medical Sciences
2 shared publications
In database
- Author Correction: Reversal of the diabetic bone signature with anabolic therapies in mice
- THU346 Repairing Skeletal Deterioration In Diabetes With Bone Anabolic Therapies
Intawat Nookaew
University of Arkansas for Medical Sciences
2 shared publications
In database
- Author Correction: Reversal of the diabetic bone signature with anabolic therapies in mice
- THU346 Repairing Skeletal Deterioration In Diabetes With Bone Anabolic Therapies
Teresita Bellido
University of Arkansas for Medical Sciences
2 shared publications
In database
- Author Correction: Reversal of the diabetic bone signature with anabolic therapies in mice
- THU346 Repairing Skeletal Deterioration In Diabetes With Bone Anabolic Therapies
Andrew J. Kavran
University of Colorado Boulder (US)
1 shared publication
- Intermittent treatment of BRAF <sup>V600E</sup> melanoma cells delays resistance by adaptive resensitization to drug rechallenge
Kristyn R. Hayashi
University of Colorado Boulder (US)
1 shared publication
- Intermittent treatment of BRAF <sup>V600E</sup> melanoma cells delays resistance by adaptive resensitization to drug rechallenge
Joel Basken
University of Colorado Boulder (US)
1 shared publication
- Intermittent treatment of BRAF <sup>V600E</sup> melanoma cells delays resistance by adaptive resensitization to drug rechallenge
Barbara J. Brandhuber
Array BioPharma (United States) (US)
1 shared publication
- Intermittent treatment of BRAF <sup>V600E</sup> melanoma cells delays resistance by adaptive resensitization to drug rechallenge
Natalie G. Ahn
University of Colorado Boulder (US)
1 shared publication
- Intermittent treatment of BRAF <sup>V600E</sup> melanoma cells delays resistance by adaptive resensitization to drug rechallenge
Similar Researchers
Based on overlapping research topics
Han M
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Metabolism and Genetic Disorders
Pharmacological Effects and Toxicity Studies
Amy Y. Sato
University of Arkansas for Medical Sciences
Bone Metabolism and Diseases
Metabolism and Genetic Disorders
Pharmacological Effects and Toxicity Studies
Mathew Newman
Arkansas State University
Cancer Treatment and Pharmacology
Pharmacological Effects and Toxicity Studies
Molecular Biology Techniques and Applications
Alan Herrera-Rueda
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Pharmacological Effects and Toxicity Studies
Molecular Biology Techniques and Applications
Kathleen E. McGinness
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Metabolism and Genetic Disorders
Pharmacological Effects and Toxicity Studies
Richard Crownover
University of Arkansas for Medical Sciences
Metabolism and Genetic Disorders
Pharmacological Effects and Toxicity Studies
Molecular Biology Techniques and Applications